Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11976130 Antibodies against claudin 18.2 useful in cancer diagnosis

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
July 17, 2018
0
Date of Patent
May 7, 2024
0
Patent Application Number
16037759
0
Patent Citations
‌
US Patent 7193074 Secreted and transmembrane polypeptides and nucleic acids encoding the same
0
‌
US Patent 7893211 Mammalian genes; related reagents and methods
0
‌
US Patent 8088588 Genetic products differentially expressed in tumors and the use of thereof
0
‌
US Patent 8148507 Nucleic acid encoding TNFx protein
0
‌
US Patent 8168427 Monoclonal antibodies against claudin-18 for treatment of cancer
0
‌
US Patent 8425902 Monoclonal antibodies against claudin-18 for treatment of cancer
0
‌
US Patent 8426573 Nucleic acids encoding TNFγ
0
‌
US Patent 8586047 Genetic products differentially expressed in tumors and the use thereof
0
‌
US Patent 8637012 Genetic products differentially expressed in tumors and the use thereof
0
‌
US Patent 8945847 Methods and kits for ascertaining biosafety of an agent
0
•••
Patent Inventor Names
Stefan Woll
0
Rita Mitnacht-Kraus
0
Ugur Sahin
0
Ozlem Tureci
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11976130
0
Patent Primary Examiner
‌
Meera Natarajan
0
CPC Code
‌
G01N 2800/52
0
‌
A61P 37/00
0
‌
G01N 33/57492
0
‌
C07K 16/28
0
‌
C07K 16/30
0
‌
C07K 2317/34
0

Find more entities like US Patent 11976130 Antibodies against claudin 18.2 useful in cancer diagnosis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.